Acrodermatitis enteropathica: Difference between revisions
No edit summary |
|||
Line 30: | Line 30: | ||
==Presentation== | ==Presentation== | ||
Features of acrodermatitis enteropathica start appearing in the first few months of life, as the infant discontinues breast milk. There are [[erythematous]] patches and plaques of dry, scaly skin. The lesions may appear [[eczema]]tous, or may evolve further into crusted [[vesicle]]s , [[Blister|bulla]]s or [[pustule]]s. The lesions are frequent around natural orifices like the mouth (peri-oral) and anus (peri-anal), and also in hands, feet and [[scalp]]. | Features of acrodermatitis enteropathica start appearing in the first few months of life, as the infant discontinues breast milk. There are [[erythematous]] patches and plaques of dry, scaly skin. The lesions may appear [[eczema]]tous, or may evolve further into crusted [[vesicle]]s , [[Blister|bulla]]s or [[pustule]]s. The lesions are frequent around natural orifices like the mouth (peri-oral) and anus (peri-anal), and also in hands, feet and [[scalp]]. | ||
There may be [[suppurative]] [[inflammation]] of the | There may be [[suppurative]] [[inflammation]] of the nail fold surrounding the [[nail plate]] - known as [[paronychia]]. [[Alopecia]] - loss of hair from scalp, eyebrows and eyelashes may occur. The skin lesions may be secondarily infected by [[bacteria]] such as [[Staphylococcus aureus]] or [[fungus|fungi]] like [[Candida albicans]]. These skin lesions are accompanied by diarrhea. | ||
==Treatment== | ==Treatment== |
Revision as of 13:13, 29 April 2009
Acrodermatitis enteropathica | |
ICD-10 | E83.2 |
---|---|
OMIM | 201100 |
DiseasesDB | 29602 |
eMedicine | derm/5 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Acrodermatitis enteropathica is an autosomal recessive disorder characterized by periorificial (around the natural orifices) and acral (in the limbs) dermatitis, alopecia (loss of hair), and diarrhea. Similar features may be present in acquired zinc deficiency. This disease also is related to deficiency of zinc due to congenital causes. Some synonyms of this condition are:
- Brandt Syndrome
- Danbolt-Cross Syndrome
- Congenital Zinc Deficiency
Pathogenesis
The genetic mutation of SLC39A4 gene on Chromosome 8q locus 24.3 appears to be the cause. The SLC39A4 gene appears to encode a transmembrane protein that serves as a zinc uptake protein. The features of the disease usually start manifesting as an infant is weaned from breast milk. This has led some scientists to suspect that human milk contains a beneficial substance that helps uptake of zinc and prevents the disease from being manifested while an infant is on breast milk.
Presentation
Features of acrodermatitis enteropathica start appearing in the first few months of life, as the infant discontinues breast milk. There are erythematous patches and plaques of dry, scaly skin. The lesions may appear eczematous, or may evolve further into crusted vesicles , bullas or pustules. The lesions are frequent around natural orifices like the mouth (peri-oral) and anus (peri-anal), and also in hands, feet and scalp. There may be suppurative inflammation of the nail fold surrounding the nail plate - known as paronychia. Alopecia - loss of hair from scalp, eyebrows and eyelashes may occur. The skin lesions may be secondarily infected by bacteria such as Staphylococcus aureus or fungi like Candida albicans. These skin lesions are accompanied by diarrhea.
Treatment
Without treatment, the disease is fatal and affected individuals may die within a few years. However, there is no absolute treatment of the condition. Lifelong dietary zinc supplementation in the range of greater than 1-2 mg/kg of bodyweight per day is usually needed.
External links
Organizations and resources
The following organizations provide information and patient support resources:
- CLIMB (Children Living with Inherited Metabolic Diseases)
- March of Dimes Birth Defects Foundation
- American Autoimmune Related Diseases Association, Inc.
- NIH/National Digestive Diseases Information Clearinghouse